A

Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination

ACS Chemical Neuroscience

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 1

References 1

1 result